Search research articles
Contact Us
Filters
Showing results (81-90 of 214) with videos related to
Page
of 22
Sort By:
Journal of Medicinal Chemistry
|
May 26, 1995
Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies
S J Hocart, V Reddy, W A Murphy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1982
Normal cortical bone mass in patients after long term coumadin therapy
L D Piro, M P Whyte, W A Murphy, et al.
Peptides
|
September 1, 1982
Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat
J L Fries, W A Murphy, J Sueiras-Diaz, et al.
Radiology
|
November 1, 1989
Shoulder joint: arthrographic CT and long-term follow-up, with surgical correlation
A J Wilson, W G Totty, W A Murphy, et al.
Peptides
|
January 1, 1986
Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor
D H Coy, W A Murphy, V A Lance, et al.
Radiology
|
June 1, 1988
Transient osteoporosis: transient bone marrow edema?
A J Wilson, W A Murphy, D C Hardy, et al.
Radiology
|
November 1, 1979
Magnification radiography of the temporomandibular joint: technical considerations
W A Murphy, R J Adams, L A Gilula, et al.
Skeletal Radiology
|
January 1, 1982
Tumoral calcinosis: case report and review
A F Bishop, J M Destouet, W A Murphy, et al.
Investigative Radiology
|
November 1, 1990
Magnetic resonance imaging of peripheral nerve sheath tumors. Assessment by numerical visual fuzzy cluster analysis
F A Mann, W A Murphy, W G Totty, et al.
Peptide Research
|
January 1, 1989
Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion
W A Murphy, J E Taylor, J P Moreau, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 214) with videos related to
Sort By:
Page
of 22
Journal of Medicinal Chemistry
|
May 26, 1995
Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies
S J Hocart, V Reddy, W A Murphy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1982
Normal cortical bone mass in patients after long term coumadin therapy
L D Piro, M P Whyte, W A Murphy, et al.
Peptides
|
September 1, 1982
Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat
J L Fries, W A Murphy, J Sueiras-Diaz, et al.
Radiology
|
November 1, 1989
Shoulder joint: arthrographic CT and long-term follow-up, with surgical correlation
A J Wilson, W G Totty, W A Murphy, et al.
Peptides
|
January 1, 1986
Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor
D H Coy, W A Murphy, V A Lance, et al.
Radiology
|
June 1, 1988
Transient osteoporosis: transient bone marrow edema?
A J Wilson, W A Murphy, D C Hardy, et al.
Radiology
|
November 1, 1979
Magnification radiography of the temporomandibular joint: technical considerations
W A Murphy, R J Adams, L A Gilula, et al.
Skeletal Radiology
|
January 1, 1982
Tumoral calcinosis: case report and review
A F Bishop, J M Destouet, W A Murphy, et al.
Investigative Radiology
|
November 1, 1990
Magnetic resonance imaging of peripheral nerve sheath tumors. Assessment by numerical visual fuzzy cluster analysis
F A Mann, W A Murphy, W G Totty, et al.
Peptide Research
|
January 1, 1989
Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion
W A Murphy, J E Taylor, J P Moreau, et al.
Page
of 22